Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of Who 2001 Versus Who 2008/2016 Criteria in a Large Single Center Cohort
Sofia Chiatamone Ricci(Sapienza University of Rome), Antonietta Ferretti(Policlinico Umberto I), Robin Foà(Sapienza University of Rome), Matteo Molica(Sapienza University of Rome), Daniela Diverio(Policlinico Umberto I), Giulia Ciotti(Sapienza University of Rome), Erminia Baldacci(Sapienza University of Rome), Giacinta Pistilli(Sapienza University of Rome), Chiara Lisi(Sapienza University of Rome), Maria Antonietta Arleo(Sapienza University of Rome), Ida Carmosino(Policlinico Umberto I), Cristina Santoro(Sapienza University of Rome), Marco Vignetti(Fondazione Gimema Onlus), Elena Mariggiò(Policlinico Umberto I), Luisa Bizzoni(Sapienza University of Rome), Marco Mancini(Radboud University Nijmegen), Stefania Trasarti(Sapienza University of Rome), Maria Lucia De Luca(Sapienza University of Rome), Massimo Breccia(Policlinico Umberto I), Daniela De Benedittis(Sapienza University of Rome), Sara Mohamed(Royal College of Surgeons in Ireland - Bahrain), Annalisa Mancuso(Sapienza University of Rome), Roberto Latagliata(Ospedale di Belcolle)
Cited by 0
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity
|Cytokine|2015|505
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464